Pharma Journalist -

Pfizer Inc. announced that the European Commission (EC) granted marketing authorization for LORVIQUA (lorlatinib, available in the U.S. under the brand name LORBRENA) as monotherapy for…
Read More...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to extend the approval of Dupixent (dupilumab) in the…
Read More...

SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control…
Read More...

SMi Group reports: Invitation letter released from Jim Polarine at STERIS who is chairing the 5th  Annual Pharmaceutical Microbiology East Coast Conference SMi Group is delighted to…
Read More...

SMi Group Reports: The leading Pain Therapeutics Conference will take place for its 22nd consecutive year on 4th and 5th May 2022 in London, UK to explore novel compounds and treatments…
Read More...

SMi Group reports: 5th Annual 3D Cell Culture Conference in February 2022 is taking place in less than two weeks as a virtual conference In less than two weeks, SMi's 5th Annual…
Read More...

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) announced that it has entered into an agreement to acquire a cell therapy manufacturing facility…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the adjuvant…
Read More...

Cocrystal Pharma, Inc. has selected two investigational novel antiviral drug candidates for further development as oral treatments for SARS-CoV-2, the virus that causes COVID-19.…
Read More...